Rickard E. Malmström

2.8k total citations
78 papers, 1.6k citations indexed

About

Rickard E. Malmström is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Rickard E. Malmström has authored 78 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cardiology and Cardiovascular Medicine, 19 papers in Economics and Econometrics and 15 papers in Cellular and Molecular Neuroscience. Recurrent topics in Rickard E. Malmström's work include Atrial Fibrillation Management and Outcomes (21 papers), Pharmaceutical Economics and Policy (16 papers) and Health Systems, Economic Evaluations, Quality of Life (15 papers). Rickard E. Malmström is often cited by papers focused on Atrial Fibrillation Management and Outcomes (21 papers), Pharmaceutical Economics and Policy (16 papers) and Health Systems, Economic Evaluations, Quality of Life (15 papers). Rickard E. Malmström collaborates with scholars based in Sweden, United Kingdom and Slovenia. Rickard E. Malmström's co-authors include Jovan P. Antović, Brian Godman, Paul Hjemdahl, Mika Skeppholm, Jan M. Lundberg, Anton Pohanka, Yuko Rönquist-Nii, Björn Wettermark, Lars L. Gustafsson and Olof Beck and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Scientific Reports and European Heart Journal.

In The Last Decade

Rickard E. Malmström

75 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rickard E. Malmström Sweden 24 671 317 305 221 219 78 1.6k
Maria Carla Roncaglioni Italy 25 1.5k 2.2× 196 0.6× 306 1.0× 55 0.2× 313 1.4× 101 3.8k
James S. Floyd United States 25 639 1.0× 89 0.3× 88 0.3× 90 0.4× 216 1.0× 81 1.9k
Vittorio Bertelè Italy 28 419 0.6× 620 2.0× 138 0.5× 21 0.1× 143 0.7× 85 2.2k
Patricia Howard United States 21 1.4k 2.1× 188 0.6× 604 2.0× 18 0.1× 97 0.4× 86 2.6k
S. Harder Germany 20 197 0.3× 59 0.2× 71 0.2× 44 0.2× 110 0.5× 73 1.2k
Patricia R. Hebert United States 23 1.4k 2.1× 251 0.8× 58 0.2× 22 0.1× 297 1.4× 49 3.0k
Thomas C. Smitherman United States 18 1.7k 2.5× 62 0.2× 314 1.0× 53 0.2× 126 0.6× 46 2.5k
Humberto Vidaillet United States 28 3.1k 4.6× 282 0.9× 138 0.5× 75 0.3× 937 4.3× 78 4.8k
Shashank Rohatagi United States 27 706 1.1× 32 0.1× 326 1.1× 41 0.2× 202 0.9× 83 2.2k
Heather Halls Australia 8 460 0.7× 36 0.1× 180 0.6× 43 0.2× 96 0.4× 13 1.6k

Countries citing papers authored by Rickard E. Malmström

Since Specialization
Citations

This map shows the geographic impact of Rickard E. Malmström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rickard E. Malmström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rickard E. Malmström more than expected).

Fields of papers citing papers by Rickard E. Malmström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rickard E. Malmström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rickard E. Malmström. The network helps show where Rickard E. Malmström may publish in the future.

Co-authorship network of co-authors of Rickard E. Malmström

This figure shows the co-authorship network connecting the top 25 collaborators of Rickard E. Malmström. A scholar is included among the top collaborators of Rickard E. Malmström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rickard E. Malmström. Rickard E. Malmström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mijovski, Mojca Božič, Alenka Mavri, Jovan P. Antović, Rickard E. Malmström, & Désirée Coen Herak. (2025). Multicenter Evaluation of Different Anti-Xa Assays and Diluted Russell’s Viper Venom Time in Ex Vivo Plasma Samples from Patients Treated with Rivaroxaban or Apixaban. Journal of Clinical Medicine. 14(23). 8274–8274.
2.
Holm, Johan, Buster Mannheimer, Rickard E. Malmström, Erik Eliasson, & Jonatan D. Lindh. (2020). Bleeding and thromboembolism due to drug-drug interactions with non-vitamin K antagonist oral anticoagulants—a Swedish, register-based cohort study in atrial fibrillation outpatients. European Journal of Clinical Pharmacology. 77(3). 409–419. 22 indexed citations
3.
Tan, Shuai, Shuijie Li, Yanan Min, et al.. (2020). Platelet factor 4 enhances CD4+ T effector memory cell responses via Akt‐PGC1α‐TFAM signaling‐mediated mitochondrial biogenesis. Journal of Thrombosis and Haemostasis. 18(10). 2685–2700. 25 indexed citations
4.
Linder, Marie, et al.. (2020). Risk factors for severe bleeding events during warfarin treatment: the influence of sex, age, comorbidity and co-medication. European Journal of Clinical Pharmacology. 76(6). 867–876. 21 indexed citations
5.
Bastholm‐Rahmner, Pia, Lars L. Gustafsson, Jaran Eriksen, et al.. (2018). Patients’ knowledge and attitudes to the Wise List - a drug formulary from the Stockholm Drug and Therapeutic committee. BMC Health Services Research. 18(1). 176–176.
6.
Eriksson, I, Thomas Cars, Fredrik Piehl, et al.. (2017). Persistence with dimethyl fumarate in relapsing-remitting multiple sclerosis: a population-based cohort study. European Journal of Clinical Pharmacology. 74(2). 219–226. 23 indexed citations
7.
Antovič, Aleksandra, Maria Berndtsson, Agnes Rasmuson, et al.. (2017). Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting. Thrombosis and Haemostasis. 117(9). 1700–1704. 37 indexed citations
8.
Eriksen, Jaran, Lars L. Gustafsson, Pia Bastholm‐Rahmner, et al.. (2017). High adherence to the ‘Wise List’ treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines. BMJ Open. 7(4). e014345–e014345. 70 indexed citations
9.
Guðmundsdóttir, Brynja R., C. W. Francis, Robert C. Gosselin, et al.. (2016). A single test to assay warfarin, dabigatran, rivaroxaban, apixaban, unfractionated heparin, and enoxaparin in plasma. Journal of Thrombosis and Haemostasis. 14(5). 1043–1053. 11 indexed citations
10.
Malmström, Rickard E., Jovan P. Antović, Anton Pohanka, et al.. (2016). Clinical evaluation of laboratory methods to monitor exposure of rivaroxaban at trough and peak in patients with atrial fibrillation. European Journal of Clinical Pharmacology. 72(6). 671–679. 28 indexed citations
11.
Skeppholm, Mika, Paul Hjemdahl, Jovan P. Antović, et al.. (2014). On the monitoring of dabigatran treatment in “real life” patients with atrial fibrillation. Thrombosis Research. 134(4). 783–789. 42 indexed citations
12.
Godman, Brian, Iain Bishop, Stephen Campbell, Rickard E. Malmström, & Ilse Truter. (2014). Quality and efficiency of statin prescribing across countries with a special focus on South Africa; findings and future implications. Expert Review of Pharmacoeconomics & Outcomes Research. 15(2). 323–330. 8 indexed citations
13.
Cars, Thomas, Björn Wettermark, Rickard E. Malmström, et al.. (2012). Extraction of Electronic Health Record Data in a Hospital Setting : Comparison of Automatic and Semi-Automatic Methods Using Anti-TNF Therapy as Model. Pharmacoepidemiology and Drug Safety. 21. 175–176. 2 indexed citations
14.
Bucsics, Anna, et al.. (2012). Influence of lifting prescribing restrictions for losartan on subsequent sartan utilization patterns in Austria: implications for other countries. Expert Review of Pharmacoeconomics & Outcomes Research. 12(6). 809–819. 17 indexed citations
15.
Malmström, Rickard E., Magnus Settergren, & John Pernow. (2009). Endothelin attenuates endothelium‐dependent platelet inhibition in man. Acta Physiologica. 198(4). 441–448. 7 indexed citations
16.
Settergren, Magnus, Felix Böhm, Rickard E. Malmström, Keith M. Channon, & John Pernow. (2008). L-arginine and tetrahydrobiopterin protects against ischemia/reperfusion-induced endothelial dysfunction in patients with type 2 diabetes mellitus and coronary artery disease. European Heart Journal. 29. 714–714. 1 indexed citations
17.
Malmström, Rickard E., et al.. (2003). Endogenous Nitric Oxide Release by Vasoactive Drugs Monitored in Exhaled Air. American Journal of Respiratory and Critical Care Medicine. 168(1). 114–120. 19 indexed citations
18.
Malmström, Rickard E., Jon O. Lundberg, & Eddie Weitzberg. (2002). Autoinhibitory function of the sympathetic prejunctional neuropeptide Y Y2 receptor evidenced by BIIE0246. European Journal of Pharmacology. 439(1-3). 113–119. 18 indexed citations
19.
Malmström, Rickard E., et al.. (2000). In Vivo Characterization of the Novel Neuropeptide Y Y1 Receptor Antagonist H 409/22. Journal of Cardiovascular Pharmacology. 36(4). 516–525. 18 indexed citations
20.
Malmström, Rickard E., Agnes Modin, & Jan M. Lundberg. (1996). SR 120107A antagonizes neuropeptide Y Y1 receptor mediated sympathetic vasoconstriction in pigs in vivo. European Journal of Pharmacology. 305(1-3). 145–154. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026